Evidence map›Paper›PMID 41915038›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Bayesian modelling demonstrates clinically relevant heterogeneity in Tau PET patterns in Alzheimer's disease.

Ye Xia, Keith Johnson, Georges El Fakhri, Nicolas J Guehl, Elsmarieke van de Giessen, Emma C Coomans, Yolande A L Pijnenburg, Rik Ossenkoppele, Colin Groot

Abstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ye XiaDepartment of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Keith JohnsonDepartment of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Georges El FakhriDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.
Nicolas J GuehlDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.
Elsmarieke van de GiessenAmsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands.
Emma C CoomansDepartment of Neurology, Alzheimer Center Amsterdam, Amsterdam UMC, Amsterdam Neuroscience, Amsterdam, Netherlands.
Yolande A L PijnenburgDepartment of Neurology, Alzheimer Center Amsterdam, Amsterdam UMC, Amsterdam Neuroscience, Amsterdam, Netherlands.
Rik OssenkoppeleDepartment of Neurology, Alzheimer Center Amsterdam, Amsterdam UMC, Amsterdam Neuroscience, Amsterdam, Netherlands.
Colin GrootDepartment of Neurology, Alzheimer Center Amsterdam, Amsterdam UMC, Amsterdam Neuroscience, Amsterdam, Netherlands. c.groot3@amsterdamumc.nl.ORCID 0000-0002-5802-6946

Funding

Alzheimer Nederland WE.03-2024-06H2020 European Research Council 949570ZonMw 10510022110010
6 · The paper itself

Abstract

backgroundTraditionally, subgroups have been used to explore the effects of tau heterogeneity on cognition. However, categorization into rigid, exclusive subtypes, each with their own tau pattern, may overlook the fact that individual tau patterns are complex, and most individuals express features of multiple patterns. Mapping tau patterns in all their complexity has important clinical implications, as it may enable more accurate prognostication and support the development of personalized therapeutic strategies tailored to an individual’s unique tau profile.

methodsWe applied a data-driven Bayesian model using Latent Dirichlet Allocation (LDA) to identify four covarying tau PET patterns in amyloid-positive individuals with symptomatic Alzheimer’s disease (AD) from the Amsterdam Dementia Cohort (ADC, N = 93, mean age = 65.3). The four latent tau spatial patterns identified via LDA were designated as follows: Limbic (Factor 1), characterized by predominant involvement of the limbic regions; Left TPC (Factor 2), centered on the left temporo-parietal cortex (TPC); Posterior (Factor 3), reflecting a posterior neocortical distribution; and MTL-sparing (Factor 4), showing relative sparing of limbic regions with diffuse neocortical tau deposition. Associations between individual loadings on each of these factors and cognitive domain scores were assessed using linear regression analyses. We then applied the ADC-derived model to an independent validation sample from the Alzheimer’s Disease Neuroimaging Initiative (ADNI, N = 162, mean age = 72.7) to extract individual factor loadings. Associations between factor loadings and contemporaneous cognitive performance were again tested using linear regression, and linear mixed-effects models were used to additionally explore associations with cognitive decline. All analyses were adjusted for age, sex, education, and clinical diagnosis.

resultsIn both the discovery and validation cohort, we identified distinct associations between tau factor loadings and cognitive performance. Higher loading on Factor 1: limbic tau was generally associated with relatively better baseline cognition and slower cognitive decline. Factor 2: left TPC tau was linked to worse baseline scores and faster decline in memory, MMSE and language scores but only in the ADNI cohort. Factor 3: posterior tau was associated with worse baseline MMSE in the ADC cohort and to worse visuospatial performance both cross-sectionally and longitudinally in the ADNI cohort. Factor 4: MTL-sparing tau was related to better longitudinal memory in the ADNI cohort.

conclusionThis data-driven approach identified overlapping tau patterns that relate to distinct cognitive domains. The findings highlight the value of continuous factor modeling in understanding heterogeneity in Alzheimer’s disease. Such a refinement of quantifying tau heterogeneity may improve patient stratification, refine prognostic accuracy, and ultimately guide the development of individualized treatment strategies.

Indexed as

Alzheimer DiseasePositron-Emission Tomographytau ProteinsAgedBayes TheoremFemaleHumansMaletau ProteinsAlzheimer’s diseaseHeterogeneityLatent Dirichlet AllocationPETTau

Identifiers

PMID41915038
PMCPMC13197381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.